首页> 外国专利> ORALLY ADMINISTERED SOLID COMPOSITE FORMULATION COMPRISING DIPEPTIDYL PEPTIDASE-4 INHIBITOR AND METFORMIN, AND PREPARATION METHOD THEREFOR

ORALLY ADMINISTERED SOLID COMPOSITE FORMULATION COMPRISING DIPEPTIDYL PEPTIDASE-4 INHIBITOR AND METFORMIN, AND PREPARATION METHOD THEREFOR

机译:包含二肽peppidase-4抑制剂和二甲双胍的口服减缓固体复合制剂及其制备方法

摘要

The present invention relates to an orally administered solid composite formulation comprising a dipeptidyl peptidase-4 inhibitor and metformin, and a preparation method therefor. Specifically, an orally administered solid composite formulation comprises wet granules prepared by homogeneously mixing a granulation composition comprising a dipeptidyl peptidase-4 inhibitor or a pharmaceutically acceptable salt thereof, and metformin or a pharmaceutically acceptable salt thereof. An orally administered solid composite formulation according to the present invention has excellent productivity and stability effects.
机译:本发明涉及包含二肽基肽酶-4抑制剂和二甲双胍的口服固体复合制剂及其制备方法。具体地,口服固体复合制剂包括通过将包含二肽基肽酶-4抑制剂或其药学上可接受的盐的颗粒组合物与二甲双胍或其药学上可接受的盐均匀混合而制备的湿颗粒。根据本发明的口服固体复合制剂具有优异的生产率和稳定性效果。

著录项

  • 公开/公告号WO2020027488A1

    专利类型

  • 公开/公告日2020-02-06

    原文格式PDF

  • 申请/专利权人 HANMI PHARM. CO. LTD.;

    申请/专利号WO2019KR09157

  • 申请日2019-07-24

  • 分类号A61K9/16;A61K31/522;A61K31/4985;A61K31/40;A61K31/155;

  • 国家 WO

  • 入库时间 2022-08-21 11:13:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号